Showing results (31-40 of 71) with videos related to
Sort By:
Pageof 8
Cancer Immunology, Immunotherapy : CII|October 26, 2010
Primed tumor-reactive multifunctional CD62L+ human CD8+ T cells for immunotherapyMatthias Wölfl, Katharina Merker, Henner Morbach, et al.European Journal of Immunology|March 3, 2015
CD28/CTLA-4/B7 costimulatory pathway blockade affects regulatory T-cell function in autoimmunityIsabel Vogel, Ahmad Kasran, Jonathan Cremer, et al.International Journal of Cancer|July 7, 2017
Characterization of PD-1 upregulation on tumor-infiltrating lymphocytes in human and murine gliomas and preclinical therapeutic blockadeJoost Dejaegher, Tina Verschuere, Ellen Vercalsteren, et al.Neuro-Oncology|April 2, 2009
DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental gliomaWim Maes, Georgina Galicia Rosas, Bert Verbinnen, et al.Journal of Neuro-Oncology|April 29, 2006
Maintenance treatment with interferon-gamma and low-dose cyclophosphamide for pediatric high-grade gliomaJohannes E A Wolff, Sabine Wagner, Christiane Reinert, et al.Cancers|February 25, 2023
Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute ExperienceStefaan W Van Gool, Jennifer Makalowski, Peter Van de Vliet, et al.Neuroradiology|November 26, 2010
MR perfusion and diffusion imaging in the follow-up of recurrent glioblastoma treated with dendritic cell immunotherapy: a pilot studyMatej Vrabec, Sofie Van Cauter, Uwe Himmelreich, et al.Methods in Molecular Biology (Clifton, N.J.)|May 30, 2016
mRNA Electroporation of Dendritic Cells with WT1, Survivin, and TriMix (a Mixture of caTLR4, CD40L, and CD70)An Coosemans, Sandra Tuyaerts, Kim Morias, et al.Anticancer Research|September 12, 2013
Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcomaAn Coosemans, Anke Vanderstraeten, Sandra Tuyaerts, et al.Cancers|November 9, 2013
Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?Matthias van Woensel, Nathalie Wauthoz, Rémi Rosière, et al.Pageof 8